Abbott Laboratories said it will pay $1.6 billion to settle federal and state claims resulting from an investigation into its epilepsy medication Depakote, the second-largest drug-marketing ...

Abbott Labs was hit with a $1.6 billion penalty to settle an investigation of improper marketing of neurologic medicine Depakote.

Abbott Laboratories said it will pay $1.6 billion to settle federal and state claims that it improperly marketed the neurological medication Depakote for off-label uses. Abbott will pay $800 ...

Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the anti-seizure drug Depakote for uses that were not approved by the Food and Drug Admini ...

Global pharmaceutical giant Abbott Laboratories has agreed to pay federal and state governments $1.6 billion in criminal and civil fines for illegally promoting unapproved uses of its drug ...

Abbott Laboratories has agreed to pay at least $1.3 billion to settle claims by the U.S. government and 24 states alleging the company illegally marketed its Depakote epilepsy drug, people familiar… ...

Abbott Laboratories said Monday that it will pay $1.6 billion to settle federal and state claims that it illegally marketed the anti-seizure medication Depakote for uses not approved by the Food ...

Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability stemming from its off-label promotion of Depakote, a drug that controls seizures. The ...

A class-action lawsuit over the illegal marketing of epilepsy drug Depakote could leave AbbVie Inc. — but not Abbott Laboratories — holding the bag. The complaint, filed by three union health ...

The drugmaker has agreed to pay $1.6 billion in fines and civil penalties to wrap up a long-running probe of its Depakote ... Abbott will pay a $500 million criminal fine and forfeit $198.5 ...

CHICAGO (CN) – A federal judge upheld a shareholder derivative lawsuit against Abbott Labs for its off-label marketing of Depakote, which cost the company a $1.3 billion settlement. Abbott ...

Depakote and Depakene are marketed by Abbott Labs. Epilim is marketed by Sanofi-Aventis. Here's Reuters' take. Here's some history from The Sun -- Britain's most reliable newspaper!